Related Experiment Video
Updated: Feb 26, 2026
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Testing PARP Inhibitors Using a Murine Xenograft Model
Peter Makhov1, Sei Naito2, Vladimir M Kolenko3
1Cancer Biology Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
Abstract:
Animal models are indispensable research tools for various drug discovery and development applications. In cancer research, the growth of tumors in vivo is necessary in order to closely modulate a potential response in humans. Ectopic (subcutaneous) xenografting of human cancer cells into immunodeficient mice has long been the standard model for preclinical evaluation of novel antitumor therapeutic agents. Here, we describe the establishment and use of subcutaneous xenograft mouse model to evaluate the antitumor activity of PARP-1 inhibitors.
Insights
Subcutaneous xenograft mouse models are vital for cancer research, enabling the evaluation of new antitumor drugs. This study details using this model to assess the efficacy of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.
Area of Science:
- Oncology
- Pharmacology
- Preclinical Research
Background:
- Animal models are crucial for drug discovery and development.
- In vivo tumor growth is essential for predicting human responses to cancer therapies.
- Ectopic xenografting in immunodeficient mice is a standard preclinical model.
Purpose of the Study:
- To establish and utilize a subcutaneous xenograft mouse model.
- To evaluate the antitumor activity of PARP-1 inhibitors.
Main Methods:
- Establishment of a subcutaneous xenograft mouse model using human cancer cells.
- Administration of PARP-1 inhibitors to evaluate antitumor effects.
Main Results:
- The study successfully established the xenograft model.
- The model was used to assess the antitumor activity of PARP-1 inhibitors.
Conclusions:
- The subcutaneous xenograft mouse model is effective for evaluating PARP-1 inhibitors.
- This model serves as a valuable tool in preclinical cancer research.
More Related Videos
06:21Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
07:10Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
Published on: March 7, 2011